Source: Virtual Congress 2020 – Possible scenarios in the challenging future of rare diffuse parenchymal lung diseases
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
D. Castillo Villegas (Barcelona, Spain), S. Barril Farre (Barcelona, Spain), P. Millan Billi (Barcelona, Spain), O. Sibila Vidal (Barcelona, Spain), A. Luque (Madrid, Spain), P. Acebo (Madrid, Spain), S. Hortelano Blanco (Madrid, Spain). Bronchoalveolar lavage cytokine profile in patients with Pulmonary Langerhans Cell Histiocytosis differs from other interstitial lung diseases. 5253

Member's Comments

No comment yet.

Related content which might interest you:

• The impact of anti-IgE treatment on the airway microbiome in asthma.
• Interstitial lung disease (ILD) and multicompartment assessment of CTD: where should the respiratory physician begin?
• Does “UIPAF” really exist?